Production improvement of FK506 in Streptomyces tsukubaensis by metabolic engineering strategy

J Appl Microbiol. 2023 Jul 4;134(7):lxad142. doi: 10.1093/jambio/lxad142.

Abstract

Aims: Study of the effect of isoleucine on the biosynthesis of FK506 and modification of its producing strain to improve the production of FK506.

Methods and results: Metabolomics analysis was conducted to explore key changes in the metabolic processes of Streptomyces tsukubaensis Δ68 in medium with and without isoleucine. In-depth analysis revealed that the shikimate pathway, methylmalonyl-CoA, and pyruvate might be the rate-limiting factors in FK506 biosynthesis. Overexpression of involved gene PCCB1 in S. tsukubaensis Δ68, a high-yielding strain Δ68-PCCB1 was generated. Additionally, the amino acids supplement was further optimized to improve FK506 biosynthesis. Finally, FK506 production was increased to 929.6 mg L-1, which was 56.6% higher than that in the starter strain, when supplemented isoleucine and valine at 9 and 4 g L-1, respectively.

Conclusions: Methylmalonyl-CoA might be the key rate-limiting factors in FK506 biosynthesis and overexpression of the gene PCCB1 and further addition of isoleucine and valine could increase the yield of FK506 by 56.6%.

Keywords: FK506; feeding strategies; metabolic engineering; metabolomics.

MeSH terms

  • Immunosuppressive Agents*
  • Isoleucine
  • Metabolic Engineering
  • Tacrolimus* / chemistry
  • Tacrolimus* / metabolism
  • Valine

Substances

  • Tacrolimus
  • Immunosuppressive Agents
  • Isoleucine
  • shikimate
  • Valine

Supplementary concepts

  • Streptomyces tsukubensis